Paweł Śledziński

441 citations
14 papers · 324 indexed · h-index 8
Topics
Cannabis and Cannabinoid Research (5 papers)CRISPR and Genetic Engineering (3 papers)GABA and Rice Research (3 papers)
Partner nations
Poland

In The Last Decade

Paweł Śledziński

13 papers receiving 314 citations

Peers

Paweł Śledziński
Comparison fields: 5 of 79
  • Molecular Biology 142
  • Pharmacology 133
  • Plant Science 40
  • Cellular and Molecular Neuroscience 38
  • Surgery 36
Replace Michelle Reiser with:
Michelle Reiser United States
Sonia M. Vallabh United States
Jagadish Loganathan United States
Qizong Lao United States
Praveen K. Sobhan India
Sara M. Nowinski United States
Jae Jin An South Korea
Aline de Araújo Brasil Brazil
Chu Xue China
Klaus Deckmann Germany
Paweł Śledziński relative to Michelle Reiser United States Michelle Reiser's profile →
Citations per field
00.5×8.9×
Michelle Reiser · 1×
Citations per year

Countries citing papers authored by Paweł Śledziński

Since Specialization
Citations

This map shows the geographic impact of Paweł Śledziński's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paweł Śledziński with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paweł Śledziński more than expected).

Fields of papers citing papers by Paweł Śledziński

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paweł Śledziński. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paweł Śledziński. The network helps show where Paweł Śledziński may publish in the future.

Co-authorship network of co-authors of Paweł Śledziński

This figure shows the co-authorship network connecting the top 25 collaborators of Paweł Śledziński. A scholar is included among the top collaborators of Paweł Śledziński based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paweł Śledziński. Paweł Śledziński is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 0
2 1
3 7
4 3
5 18
6 19
7 10
8 34
9 37
10 1
11 120
12 53
13 18
14 3

About Paweł Śledziński

Paweł Śledziński is a scholar working on Aging, Pharmacology and Endocrinology, having authored 14 papers that have together received 324 indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (5 papers), CRISPR and Genetic Engineering (3 papers) and GABA and Rice Research (3 papers). The work is most often cited by research in Pharmacology (133 citations), Business and International Management (14 citations) and Aging (6 citations). Paweł Śledziński has collaborated with scholars based in Poland. Frequent co-authors include Agnieszka Nowak, Joanna Zeyland, Ryszard Słomski, Marta Olejniczak, Bartosz F. Grześkowiak, Daniel Lipiński, Magdalena Hryhorowicz, Izabela Szczerbal, Monika Stachowiak and Stanisław Dzimira. Their work appears in journals such as Scientific Reports, International Journal of Molecular Sciences and Molecules.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026